News

Enlyten Medical Technologies is based in the Netherlands with operations in Israel and offices in the US. Mr Raz served as CEO and chairman in the main defense

Mr Goolsby agreed to provide consulting services to the company until January 2009. Richard Rusk, currently vice president, treasurer and controller of the company, will assume the role

Mr Sachs will be responsible for the creation and execution of Carestream Health’s merger and acquisition strategy and for the development of strategic growth plans. Most recently, Mr

The combination of BTG and Protherics is intended to create a profitable specialty pharmaceuticals business with significant revenues and royalties from both marketed products and partnered development programs.

The results confirm a continued benefit of initiating treatment with Betaseron shortly after the first event. The study also demonstrated that early treatment with Betaseron had a beneficial

Previously, the company announced the trial met its primary endpoint with a significantly greater proportion of people taking Fampridine-SR having a consistent improvement in walking speed compared to

However, this finding did not achieve statistical significance. In addition, the study did not achieve statistical significance with its primary endpoint, the cumulative number of gadolinium-enhanced brain lesions.

The supplemental biologics license application (sBLA) will propose a label expansion to include use of the Zevalin therapeutic regimen ((90Y)-ibritumomab tiuxetan) as consolidation therapy after remission induction in

The first application to be addressed under this agreement will include adaptive gating, the capability of automatically interrupting the radiation beam from a linear accelerator in response to